Cargando…
P1175: REAL LIFE OUTCOMES OF RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE CENTRE EXPERIENCE
Autores principales: | Dogliotti, I., Clerico, M., Vassallo, F., Ragaini, S., Peri, V., Botto, B., Consoli, C., Orsucci, L., Freilone, R., Ferrero, S., Lonardo, A., De Luca, G., Ferrero, D., Cavallo, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431355/ http://dx.doi.org/10.1097/01.HS9.0000847564.07018.d5 |
Ejemplares similares
-
P1171: CNS RELAPSE OF DIFFUSE LARGE B-CELL LYMPHOMA. CLINICAL PRESENTATION, OUTCOME AND ROLE OF UPFRONT PROPHYLAXIS: A 10-YEAR SINGLE CENTER EXPERIENCE.
por: Benevolo Savelli, Corrado, et al.
Publicado: (2023) -
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia
por: Dogliotti, Irene, et al.
Publicado: (2021) -
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
por: Clerico, Michele, et al.
Publicado: (2022) -
Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up
por: Parisi, Mattia, et al.
Publicado: (2022) -
COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment
por: Clerico, Michele, et al.
Publicado: (2021)